FI50416C - Process for the preparation of new therapeutically useful trisubstituted branches sols and thiazoles and their acid addition salts - Google Patents

Process for the preparation of new therapeutically useful trisubstituted branches sols and thiazoles and their acid addition salts

Info

Publication number
FI50416C
FI50416C FI304067A FI304067A FI50416C FI 50416 C FI50416 C FI 50416C FI 304067 A FI304067 A FI 304067A FI 304067 A FI304067 A FI 304067A FI 50416 C FI50416 C FI 50416C
Authority
FI
Finland
Prior art keywords
thiazoles
sols
trisubstituted
branches
preparation
Prior art date
Application number
FI304067A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI50416B (en
Inventor
Kevan Brown
John Frederick Cavalla
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51823/66A external-priority patent/GB1145884A/en
Priority claimed from GB5620366A external-priority patent/GB1206403A/en
Priority claimed from GB2626267A external-priority patent/GB1147626A/en
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of FI50416B publication Critical patent/FI50416B/fi
Publication of FI50416C publication Critical patent/FI50416C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
FI304067A 1966-11-18 1967-11-10 Process for the preparation of new therapeutically useful trisubstituted branches sols and thiazoles and their acid addition salts FI50416C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB51823/66A GB1145884A (en) 1966-11-18 1966-11-18 Thiazole derivatives
GB5620366A GB1206403A (en) 1966-12-15 1966-12-15 Oxazoles
GB2507667 1967-05-31
GB2626267A GB1147626A (en) 1966-07-15 1967-06-07 Thiazole derivatives
GB2738267 1967-06-14

Publications (2)

Publication Number Publication Date
FI50416B FI50416B (en) 1975-12-01
FI50416C true FI50416C (en) 1976-03-10

Family

ID=27516268

Family Applications (1)

Application Number Title Priority Date Filing Date
FI304067A FI50416C (en) 1966-11-18 1967-11-10 Process for the preparation of new therapeutically useful trisubstituted branches sols and thiazoles and their acid addition salts

Country Status (12)

Country Link
JP (1) JPS4938267B1 (en)
BE (1) BE706625A (en)
CH (9) CH545310A (en)
DE (2) DE1670005C2 (en)
ES (1) ES347319A1 (en)
FI (1) FI50416C (en)
FR (2) FR1584222A (en)
IL (1) IL28803A (en)
LU (1) LU54891A1 (en)
NL (1) NL157012B (en)
PL (1) PL72562B1 (en)
SE (2) SE369307B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096994A1 (en) * 1970-07-24 1972-03-03 Roussel Uclaf 2-para-cyclopropyl phenyl-4-(halo)phenyl-5-thiazolyl - alkanoic acids -antiinflammatory analgesic, antipyretic agents
JPS5113375U (en) * 1974-07-18 1976-01-30
JPS5182675A (en) * 1975-01-17 1976-07-20 Tokyo Shibaura Electric Co
GB1543154A (en) * 1975-05-02 1979-03-28 Lilly Industries Ltd Urea and carbamate derivatives
US4168315A (en) * 1977-09-28 1979-09-18 The Upjohn Company Dianisyl thiazole compound, compositions and method of antithrombotic treatment
US4697012A (en) * 1984-07-25 1987-09-29 Merck & Co., Inc. Morpholino pyridyl thiazole compound
IT1204751B (en) * 1986-01-03 1989-03-10 Therapicon Srl WATER SOLUBLE ACID DERIVATIVES 4,5 -DIPHENYL-2 -XSAZOLPROPIONIC, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS
CA2074933C (en) * 1990-11-30 2002-12-03 Masatoshi Chihiro Thiazole derivatives as active superoxide radical inhibitors
CA2195847A1 (en) * 1994-07-27 1996-02-08 John J. Talley Substituted thiazoles for the treatment of inflammation
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130759C (en) * 1965-10-07

Also Published As

Publication number Publication date
FR1584222A (en) 1969-12-19
LU54891A1 (en) 1968-02-08
CH560205A5 (en) 1975-03-27
CH545309A (en) 1973-12-15
CH528531A (en) 1972-09-30
SE369307B (en) 1974-08-19
BE706625A (en) 1968-05-16
CH545310A (en) 1973-12-15
ES347319A1 (en) 1969-05-16
CH554884A (en) 1974-10-15
IL28803A (en) 1974-05-16
CH545308A (en) 1973-12-15
SE422209B (en) 1982-02-22
PL72562B1 (en) 1974-08-30
NL6715532A (en) 1968-05-20
JPS4938267B1 (en) 1974-10-16
CH556351A (en) 1974-11-29
NL157012B (en) 1978-06-15
DE1670005A1 (en) 1970-08-06
DE1795822C2 (en) 1982-07-15
CH560203A5 (en) 1975-03-27
DE1670005C2 (en) 1982-06-09
FR8018M (en) 1970-08-03
CH536311A (en) 1973-04-30
FI50416B (en) 1975-12-01

Similar Documents

Publication Publication Date Title
FI48730C (en) Process for the preparation of therapeutically useful 1-aminoalkyl-substituted phthalans and isochromanes and their acid addition salts.
FI42712C (en) Process for the preparation of therapeutically active biphenylalkane derivatives
BR6793319D0 (en) PROCESS FOR THE PREPARATION OF CARBOXYLIC ACID ESTERS AND STARCHES
FI50416C (en) Process for the preparation of new therapeutically useful trisubstituted branches sols and thiazoles and their acid addition salts
FI49024C (en) A process for the preparation of basically substituted amides of therapeutically active N-substituted anthralic acids and their salts.
CH476002A (en) Process for the preparation of therapeutically active indolylmethyl-tetrazoles
FI47881C (en) Process for the preparation of therapeutically active substituted phenylacetamides
FI41652C (en) Process for the preparation of penicillins and their non-toxic salts
FI45450C (en) A process for the preparation of therapeutically useful phentiazine derivatives and their salts
PH9433A (en) Process for the preparation of 7-aminocephalosporins and acid addition salts thereof
FI50423C (en) Process for the preparation of 6-aminopenicillanic acid
FI44596C (en) Process for the preparation of sulphonylurethanes and their salts
FI46955C (en) Process for the preparation of therapeutically active 1-p-chlorobenzoyl-2-lower alkyl-5-lower alkoxy-3-indolylacetic acid
FI44229C (en) Process for the preparation of analgesic beta-unsaturated-beta-hydroxy-beta-phenylethylamines and their acid addition salts
FI47880C (en) Process for the preparation of therapeutically active substituted phenylacetic acids
BR6676263D0 (en) PROCESS FOR THE PREPARATION OF MONOFLUOR-PHOSPHORIC ACID AND ITS MONOSTERES
NO138768C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 7-PHENYLACETAMIDOCEFALOSPORANIC ACID DERIVATIVES
BR6680070D0 (en) PROCESS FOR THE PREPARATION OF ALPHA-AMINOCARBOXYLIC ACID ESTERS
FI32770A (en) Process for the preparation of N-cycloalkylsulfamic acids and their salts
FI41272C (en) Process for the preparation of therapeutically active 4- or 5-aryl-1-naphthylacetic acids and their derivatives
FI47879C (en) Process for the preparation of therapeutically active substituted phenylacetic acid derivatives
FI43992C (en) Process for the preparation of new therapeutically useful 1-dialkylaminoalkyl-4-oxo-1,2,3,4-tetrahydroquinazolines and their acid addition salts
FI42963C (en) The process prepares new esters of secondary amino alcohols and their acid addition salts
FI43997C (en) Process for the preparation of therapeutically active imidazoline derivatives
FI48073C (en) A process for the preparation of therapeutically active sulfamoylanthranilic acid derivatives